Department of Cell and Molecular Biology, The Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA.
J Biol Chem. 2012 Nov 9;287(46):38408-25. doi: 10.1074/jbc.M112.415505. Epub 2012 Sep 17.
BACE1 is the β-secretase enzyme that initiates production of the β-amyloid peptide involved in Alzheimer disease. However, little is known about the functions of BACE1. BACE1-deficient mice exhibit mild but complex neurological phenotypes suggesting therapeutic BACE1 inhibition may not be completely free of mechanism-based side effects. Recently, we have reported that BACE1 null mice have axon guidance defects in olfactory sensory neuron projections to glomeruli in the olfactory bulb. Here, we show that BACE1 deficiency also causes an axon guidance defect in the hippocampus, a shortened and disorganized infrapyramidal bundle of the mossy fiber projection from the dentate gyrus to CA3. Although we observed that a classical axon guidance molecule, EphA4, was cleaved by BACE1 when co-expressed with BACE1 in HEK293 cells, we could find no evidence of BACE1 processing of EphA4 in the brain. Remarkably, we discovered that the axon guidance defects of BACE1(-/-) mice were strikingly similar to those of mice deficient in a recently identified BACE1 substrate, the neural cell adhesion molecule close homolog of L1 (CHL1) that is involved in neurite outgrowth. CHL1 undergoes BACE1-dependent processing in BACE1(+/+), but not BACE1(-/-), hippocampus, and olfactory bulb, indicating that CHL1 is a BACE1 substrate in vivo. Finally, BACE1 and CHL1 co-localize in the terminals of hippocampal mossy fibers, olfactory sensory neuron axons, and growth cones of primary hippocampal neurons. We conclude that BACE1(-/-) axon guidance defects are likely the result of abrogated BACE1 processing of CHL1 and that BACE1 deficiency produces a CHL1 loss-of-function phenotype. Our results imply the possibility that axon mis-targeting may occur in adult neurogenic and/or regenerating neurons as a result of chronic BACE1 inhibition and add a note of caution to BACE1 inhibitor development.
BACE1 是 β-分泌酶,可启动阿尔茨海默病相关 β-淀粉样肽的产生。然而,人们对 BACE1 的功能知之甚少。BACE1 缺陷小鼠表现出轻微但复杂的神经表型,这表明 BACE1 抑制治疗可能并非完全没有基于机制的副作用。最近,我们报道了 BACE1 缺失小鼠在嗅球中嗅感觉神经元投射到肾小球的轴突导向缺陷。在这里,我们显示 BACE1 缺乏也会导致海马中的轴突导向缺陷,齿状回向 CA3 的苔藓纤维投射的下锥体束缩短和紊乱。虽然我们观察到当 BACE1 与 BACE1 在 HEK293 细胞中共表达时,经典的轴突导向分子 EphA4 被 BACE1 切割,但我们在大脑中没有发现 BACE1 处理 EphA4 的证据。值得注意的是,我们发现 BACE1(-/-) 小鼠的轴突导向缺陷与最近发现的 BACE1 底物,神经细胞黏附分子同源物 L1 (CHL1) 缺陷小鼠的轴突导向缺陷非常相似,CHL1 参与神经突生长。CHL1 在 BACE1(+/+) 而非 BACE1(-/-) 的海马和嗅球中经历 BACE1 依赖性加工,表明 CHL1 是体内 BACE1 的底物。最后,BACE1 和 CHL1 在海马苔藓纤维的末端、嗅感觉神经元轴突和海马原代神经元的生长锥中共定位。我们得出结论,BACE1(-/-) 轴突导向缺陷可能是由于 BACE1 对 CHL1 的加工中断所致,并且 BACE1 缺乏会产生 CHL1 功能丧失表型。我们的结果表明,由于慢性 BACE1 抑制,成年神经发生和/或再生神经元可能发生轴突靶向错误,并为 BACE1 抑制剂的开发敲响警钟。